跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,709 条关于
“TROPION-Breast01”
全部
18,709
临床试验
17,561
药物
80
机构
11
资讯
1,057
2年前
Datopotamab Deruxtecan Fails to Meet Overall Survival Endpoint in TROPION-Breast01 Trial
2年前
FDA Accepts Datopotamab Deruxtecan BLA for HR-Positive, HER2-Negative Metastatic Breast Cancer
去年
Datopotamab Deruxtecan's Role in HR+/HER2- Breast Cancer Treatment: Sequencing and Safety Considerations
去年
Datroway (Datopotamab Deruxtecan) Receives Global Approvals for Advanced Breast Cancer
去年
DATROWAY® (Datopotamab Deruxtecan) Receives EU Approval for Previously Treated Metastatic HR+/HER2- Breast Cancer
去年
TROP2-Directed Therapies Show Promise in Breast and Lung Cancers
2年前
FDA Accepts Datopotamab Deruxtecan BLA for Nonsquamous NSCLC Treatment
去年
Mixed Results for Cancer and Neurological Drugs, Regulatory Scrutiny Intensifies for PBMs
去年
AstraZeneca and Daiichi Sankyo Withdraw EU Application for Lung Cancer Drug Datopotamab Deruxtecan
去年
FDA Gears Up for Critical Decisions on Alzheimer's, Breast Cancer, and Neurological Therapies in Early 2025
第 1 页,共 106 页
上一页
下一页